United Therapeutics (UTHR) Misses Q4 EPS by 21c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $516.68 -0.36%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.51, $0.21 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $427.62 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- JPMorgan Starts Toei Animation Co Ltd (4816:JP) at Neutral
- Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
